Literature DB >> 10312717

Cost of illness studies: no aid to decision making: Reply to Shiell et al. (Health Policy, 8 (1987) 317-323).

C Behrens, K Henke.   

Abstract

Efficient resource allocation in health care requires adequate techniques of collective decision making. In a recent article Shiell, Gerard and Donaldson (Health Policy 8 (1987) 317-323) claim that cost of illness studies only confuse, mask and mislead, while cost-benefit analysis provides the relevant framework for decisions in health care. We do not agree with their naive approach to decision making in health care. In comparing the two alternative methods, their respective importance for decision making becomes apparent. None of the two techniques may be considered as the one and only means to ultimately solving the problem of efficient resource allocation in health care. Yet, both techniques can provide relevant information on which policy makers can base their decisions in health care.

Mesh:

Year:  1988        PMID: 10312717     DOI: 10.1016/0168-8510(88)90002-4

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

Review 1.  Economic note: cost of illness studies.

Authors:  S Byford; D J Torgerson; J Raftery
Journal:  BMJ       Date:  2000-05-13

2.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

3.  Societal perspective on the burden of migraine in The Netherlands.

Authors:  L van Roijen; M L Essink-Bot; M A Koopmanschap; B C Michel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

4.  The burden of migraine in Spain: beyond direct costs.

Authors:  Xavier Badia; Sol Magaz; Laura Gutiérrez; Jordi Galván
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 5.  Cost-of-illness studies in diabetes mellitus.

Authors:  Lorraine Ettaro; Thomas J Songer; Ping Zhang; Michael M Engelgau
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Direct and indirect costs of asthma in Canada, 1990.

Authors:  M D Krahn; C Berka; P Langlois; A S Detsky
Journal:  CMAJ       Date:  1996-03-15       Impact factor: 8.262

7.  Cost of low back pain in Switzerland in 2005.

Authors:  Simon Wieser; Bruno Horisberger; Sara Schmidhauser; Claudia Eisenring; Urs Brügger; Andreas Ruckstuhl; Jürg Dietrich; Anne F Mannion; Achim Elfering; Ozgür Tamcan; Urs Müller
Journal:  Eur J Health Econ       Date:  2010-06-05

8.  The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches.

Authors:  T D Szucs; K Berger; D N Fisman; S Harbarth
Journal:  BMC Infect Dis       Date:  2001-06-28       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.